Genetic susceptibility and the common cancers

References

• Ayesh R., Idle J. R., Ritchie J. C., Crothers M. J., Hetzel M. R. Metabolic oxidation phenotype as markers of susceptibility tdlung cancer. Nature 1984; 312: 169–170
   PubMed Web of Science ®Google Scholar
• Bronner C. E., Baker S. M., Morrison P. T., Warren G. L.G., Lescoe M. K., Kane M., Earabwo C, Lipford J., Lindblom A., Tannergard P., Bollag R. J., Godwn A. R., Ward D. C., Norgenskiold M., Fishel R., Kolodner R., Liskay R. M. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nompolyposis colon cancer. Nature 1994; 368: 258–259
   PubMed Web of Science ®Google Scholar
• Brunner H. G., Nelen M., Breakfield X. O., Ropers H. H., van Oost A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase. Science 1993; 262: 578–580
   PubMed Web of Science ®Google Scholar
• Caporaso N., Goldstein A. Cancer genes: single and susceptibility: exposing the difference. Pharmacogenetics 1995; 5: 59–63
   PubMedGoogle Scholar
• Caporaso N., Landi M. T., Vineis P. Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of the epidemiologic evidence. Pharmacogenetics 1991; 1: 4–19
   PubMedGoogle Scholar
• Caporaso N., DeBaun M. R., Rothman N. Lung cancer and the CYP2D6 (the debrisoquine polymorphism); sources of heterogeneity in the proposed association. Pharmacogenetics 1995; 5: 129–134
   Google Scholar
• Carter B. S., Beaty T, Steinberg G. D., Childs B., Walsh P. C. Mendelian inheritance of familial prostate cancer. Proceedings of the National Academy of Sciences 1992; 89: 3367–3371
   PubMed Web of Science ®Google Scholar
• Clayton E. W., Steinberg K. K., Khoury M. J., Thomson E., Andrews L., Kahn M. E., Kopelman L. M., Weiss J. O. Informed consent for genetic research in stored tissue samples. Journal of the American Medical Association 1995; 274: 1786–1792
   PubMed Web of Science ®Google Scholar
• d'Errico, Taiou E., Chen X., Vineis P. Genetic Metabolic Polymorphisms and the Risk of Cancer: A Review of the Literature. Biomarkers, 1: 149–173
   PubMed Web of Science ®Google Scholar
• Hayney M. S., Diamanug P., Lipsky J. J., Poland G. A. Utility of a ‘Swish and Spit’ technique for the collection of buccal cells for TAP haplotype determination. Mayo Clinic Proceedings 1995; 70: 951–954
   PubMed Web of Science ®Google Scholar
• Hulka B S. Overview of Biological Markers. Biological Markers in Epidemiology. Oxford Universlty Press, New York 1990; 3–15
   Google Scholar
• Kellermann G., Shaw C. R., Luyten-Kellermann M. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. New England Journal of Medicine 1973; 298: 934–937
   Google Scholar
• Kihara M., Kihara M., Noda K. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Caninogenesis 1994; 15: 415–418
   PubMed Web of Science ®Google Scholar
• Knudson A. G., Jr. Mutation and cancer-Statistical study of retinoblastoma. Proceedings of the National Academy of Sciences 1971; 68: 820
   PubMed Web of Science ®Google Scholar
• Lower G. M., Nilsson T, Jr., Nelson C. E., Wolf H., Gamskv T. E., Bryan G. T. N-Acetyltransferase phenotype and risk of urinary bladder cancer: approaches in moleculai epidemiology. Environmental Health Perspectives 1979; 29: 71–79, Preliminary results in Sweden and Denmark.
   PubMed Web of Science ®Google Scholar
• Miki Y., Swensoen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavigian S., Liu Q., Cochran C., Bennett L. M., Ding W., Bell R., Rosenthal J., Hussey C., Tran T., et al. A strong candidate for the breast and ovarian cancer susceptibility gene, Brca1. Science 1994; 266: 66–71
   PubMed Web of Science ®Google Scholar
• Nakachi K., Imai K., Hayashi S., Watanabe J., Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Research 1991; 51: 5177–5180
   PubMed Web of Science ®Google Scholar
• Polvikoski T, Sulkava R., Haltia M., Kainulainen K., Vuorio A., Verkkoniem A., Ninisto L., Halonen P., Kontula K. Apolipoprotein E, Dementia, and Cortical deposition of B-Amyloid Protein. New England Journal of Medicine 1995; 333: 1242–1247
   PubMed Web of Science ®Google Scholar
• Ruz J., Blanche H., James R. W., Garin Blatter, McVaisse C., Charpentier G., Cohen N., Morabia A., Passa P., Froguel P. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 1995; 346: 869–872
   PubMed Web of Science ®Google Scholar
• Seidegard J., Pero R. W., Miller D. G., Beattie E. J. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986; 7: 751–753
   PubMed Web of Science ®Google Scholar
• Sellers T. A., Baley-Wlson J. E., Elston R. C., Wilson A. F., Elston G. Z., Ooi W L., et al. Evidence for Mendelian Inheritance in the Pathogenesis of Lung Cancer. Journal of the National Cancer Institute 1990; 82: 1272–1279
   PubMed Web of Science ®Google Scholar
• Sellers T. A., Chen P-L., Potter J. D., Bailey-Wilson J. E., Rothschild H., Elston R. C. Segregation Analysis of Smoking-Associated Malignancies. American Journal of Medical Genetics 1994; 52: 308–314
   PubMed Web of Science ®Google Scholar
• Sugimura H., Caporaso N. E., Modall R., Hoover R. N., Resau J. H., Trump B. F., Longeran J. A., Krontiris T. G., Mann D. L., Weston A., Harris C. C. Association of rare alleles of the Harvey ras protooncogene locus with lung cancer. Cancer Research 1990; 50: 1857–1862
   PubMed Web of Science ®Google Scholar
• Vineis P., Caporaso N. Applications of biochemical epidemiology in the study of human carcinogenesis. Tumori 1988; 74: 19–26
   PubMed Web of Science ®Google Scholar
• Vineis P., Caporaso N., Tannenbaum S. R., Skipper P. L., Glogowski J., Bartsch H., Coda M., Talaska G., Kadlubar F. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking. Cancer Research 1990; 50: 3002–3004
   PubMed Web of Science ®Google Scholar